THULIUM:YAG LASER ENUCLEATION OF THE PROSTATE (ThuLEP) - OUR EXPERIENCE IN 246 PATIENTS

Overview

Journal Acta Clin Croat

Specialty General Medicine

Date 2024 Jul 5

PMID 38966028

Authors

Nikola Zebic

Velimir Terzic

Vinko Krajina

Affiliations

Soon will be listed here.

Abstract

New minimally invasive procedures to treat benign prostatic hyperplasia (BPH) have been developed in the last 20 years. With the introduction of laser enucleation techniques in prostate surgery, previous standard surgical procedures (open retropubic or transvesical adenectomy and transurethral resection of the prostate) have become less relevant, especially in case of very large prostates. The objective of this paper is to describe the experience and results of thulium:YAG laser application in BPH treatment in our department. In the last five years, 246 patients underwent thulium:YAG laser enucleation of the prostate (ThuLEP) due to BPH or lower urinary tract symptoms following complete urologic evaluation. The mean age of our patients was 73 (range 51-95) years and mean duration of surgery was 92 minutes. The mean weight of enucleated tissue was 73 grams. A low rate of intraoperative and early postoperative complications and short length of stay proved minimal invasiveness of this procedure, which results in significant improvements in urodynamic parameters and substantially reduces the post-void residual urine volume. The most important surgical and technical characteristics (enucleation and low-power laser application) make ThuLEP a safe and efficient surgical method not limited by the prostate volume. ThuLEP has a potential to displace the current standard surgical procedures to treat BPH.

References

Madersbacher S, Lackner J, Brossner C, Rohlich M, Stancik I, Willinger M . Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005; 47(4):499-504. DOI: 10.1016/j.eururo.2004.12.010. View

Gross A, Netsch C, Knipper S, Holzel J, Bach T . Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol. 2012; 63(5):859-67. DOI: 10.1016/j.eururo.2012.11.048. View

Kuntz R, Lehrich K, Ahyai S . Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2007; 53(1):160-6. DOI: 10.1016/j.eururo.2007.08.036. View

Kim Y, Lee Y, Kwon J, Cho S, Kim J . A novel one lobe technique of thulium laser enucleation of the prostate: 'All-in-One' technique. Korean J Urol. 2015; 56(11):769-74. PMC: 4643173. DOI: 10.4111/kju.2015.56.11.769. View

Barry M, Fowler Jr F, OLeary M, Bruskewitz R, HOLTGREWE H, MEBUST W . The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992; 148(5):1549-57; discussion 1564. DOI: 10.1016/s0022-5347(17)36966-5. View

Zhang F, Shao Q, Herrmann T, Tian Y, Zhang Y . Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology. 2012; 79(4):869-74. DOI: 10.1016/j.urology.2011.12.018. View

Vavassori I, Valenti S, Naspro R, Vismara A, DellAcqua V, Manzetti A . Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol. 2007; 53(3):599-604. DOI: 10.1016/j.eururo.2007.10.059. View

Herrmann T, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M . Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010; 28(1):45-51. DOI: 10.1007/s00345-009-0503-0. View

Netsch C, Becker B, Tiburtius C, Moritz C, Venneri Becci A, Herrmann T . A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy. World J Urol. 2017; 35(12):1913-1921. DOI: 10.1007/s00345-017-2071-z. View

10.

Ahyai S, Lehrich K, Kuntz R . Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007; 52(5):1456-63. DOI: 10.1016/j.eururo.2007.04.053. View